CERE
Cerevel Therapeutics Holdings Inc
Price:  
44.96 
USD
Volume:  
15,090,400.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CERE Intrinsic Value

-128.11 %
Upside

What is the intrinsic value of CERE?

As of 2025-07-11, the Intrinsic Value of Cerevel Therapeutics Holdings Inc (CERE) is -12.64 USD. This CERE valuation is based on the model Peter Lynch Fair Value. With the current market price of 44.96 USD, the upside of Cerevel Therapeutics Holdings Inc is -128.11%.

Is CERE undervalued or overvalued?

Based on its market price of 44.96 USD and our intrinsic valuation, Cerevel Therapeutics Holdings Inc (CERE) is overvalued by 128.11%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

44.96 USD
Stock Price
-12.64 USD
Intrinsic Value
Intrinsic Value Details

CERE Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -12.64 - -12.64 -12.64 -128.11%
P/E (18.96) - (33.87) (25.65) -157.1%
DDM - Stable (25.23) - (81.06) (53.15) -218.2%
DDM - Multi (1.46) - (3.60) (2.07) -104.6%

CERE Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 8,191.26
Beta 1.22
Outstanding shares (mil) 182.19
Enterprise Value (mil) 8,208.75
Market risk premium 4.60%
Cost of Equity 8.91%
Cost of Debt 5.00%
WACC 8.75%